drugset / Trial / NCT01934777
Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this interventional study is to evaluate the efficacy and tolerability of docosahexaenoic acid (DHA), Vitamin E and Choline in children or adolescents with well-characterized and liver biopsy confirmed nonalcoholic fatty liver disease (NAFLD).
Timeline
- Start
- 2013-10
- Primary completion
- 2014-10
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Choline | Other / unclassified | 201 mg | Oral |
| Subject | DOCONEXENT | Other / unclassified | 250 mg | Oral |
| Subject | Vitamin E | Other / unclassified | 39 iu | Oral |